While DSF inhibits the ubiquitin-proteasome pathway by targeting the p97-NPL4-UFD1 axis [11], it paradoxically activates autophagy, which may attenuate its anti-tumor efficacy [31–34]. Here, UFD1 is linked to neoplasm.